Pacer Advisors, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 3 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$14,336,745
+1.7%
926,745
+3.3%
0.06%
-3.5%
Q2 2023$14,100,259
-45.7%
897,534
-43.1%
0.06%
-48.6%
Q1 2023$25,986,801
+62.3%
1,576,869
+53.6%
0.11%
+35.4%
Q4 2022$16,010,233
+13.5%
1,026,297
-5.6%
0.08%
-16.3%
Q3 2022$14,106,000
+18.7%
1,087,582
+28.5%
0.10%
+11.4%
Q2 2022$11,881,000
+94.5%
846,256
+98.4%
0.09%
+76.0%
Q1 2022$6,107,000
+68.7%
426,458
+60.6%
0.05%
+35.1%
Q4 2021$3,620,000
+41.2%
265,562
+69.7%
0.04%
+15.6%
Q3 2021$2,563,000
-3.8%
156,467
-1.2%
0.03%
-15.8%
Q2 2021$2,664,000
+10.4%
158,290
+19.8%
0.04%
-9.5%
Q1 2021$2,413,000
-4.8%
132,126
-5.2%
0.04%
-12.5%
Q4 2020$2,535,000
+345.5%
139,311
+337.0%
0.05%
+300.0%
Q3 2020$569,000
+19.5%
31,876
+32.1%
0.01%
-45.5%
Q4 2019$476,000
+62.5%
24,123
+41.7%
0.02%
+214.3%
Q3 2019$293,000
+51.8%
17,023
+55.7%
0.01%
+40.0%
Q2 2019$193,000
-89.8%
10,932
-88.3%
0.01%
-90.6%
Q1 2019$1,901,000
+18.7%
93,305
-2.0%
0.05%
-5.4%
Q4 2018$1,601,000
-31.8%
95,192
-13.4%
0.06%
-36.4%
Q3 2018$2,349,000
+12.2%
109,912
+9.7%
0.09%
-7.4%
Q2 2018$2,094,000100,2210.10%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders